Figure 2From: Molecular monitoring of minimal residual disease in two patients with MLL-rearranged acute myeloid leukemia and haploidentical transplantation after relapse Minimal residual disease (MRD) course of patient 1 over time. Three further peripheral blood samples taken at months 25, 28 and 33 were also MRD-negative (not shown in this diagram). Below the chromosomal break region with PCR primers and hydrolysis probe indicated.Back to article page